Log In
Print
BCIQ
Print
Print this Print this
 

Tigatuzumab (CS-1008)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionHumanized monoclonal antibody (mAb) targeting human death receptor 5 (DR5)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 10b (TNFRSF10B) (DR5) (TRAILR2) (CD262)
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today